April 16 (Reuters) - The U.S. Food and Drug Administration on Tuesday alerted health care professionals and consumers that unsafe counterfeit versions of AbbVie's (ABBV.N) , opens new tab Botox ...
Counterfeit Botox of AbbVie is being distributed across multiple states in the U.S. The U.S. Food and Drug Administration (FDA) warned healthcare professionals and consumers on the 16th (local ...
“Our supply chain has been infiltrated with counterfeit Botox — historically, presently, and will be in the future,” said ...
“Harmful reactions” from women in nine states led to alerts from the FDA and CDC this week about fake Botox, unlicensed medical facilities and unlicensed people giving the shots. Here’s what ...
Officials with the California Department of Public Health issued a warning Wednesday to consumers seeking Botox injections ...
The Centers for Disease Control and Prevention (CDC) is cracking down on fake Botox injections after receiving reports of 19 people in nine states who experienced "harmful reactions," the national ...
The counterfeit Botox products have caused “hospitalizations and other serious reactions,” the California Department of ...
As of April 12, a total of 19 people from nine states had reported harmful reactions after receiving Botox injections from unlicensed or untrained individuals, or in non-healthcare settings, such ...